This inventor holds 1 USPTO granted patent. Top assignee: Horizon Therapeutics USA, Inc.. Active years: 2026.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2026
Title: Swarnendra K. Verma and His Work on Gout Treatment
Introduction
Swarnendra K. Verma is an inventor based in Newport Beach, California, and is associated with Horizon Therapeutics USA, Inc. His patent work addresses treatment approaches for gout using PEGylated uricase.
Latest Patents
Verma is named on one patent, “Methods of Treating Gout.” The disclosure describes administering PEGylated uricase through an infusion lasting less than 120 minutes and using an infusion volume below 250 mL. It also describes co-administering PEGylated uricase with methotrexate (MTX), including approaches intended to reduce immunogenicity and prolong the urate-lowering effect. Verma’s listed portfolio includes 1 patent.
Career Highlights
Verma’s identified patent contribution focuses on potential ways to make PEGylated uricase treatment more practical and to support its therapeutic effects. His work is associated with Horizon Therapeutics USA, Inc.
Collaborations
Verma’s listed coworker is Paul Michael Peloso. The patent disclosure also describes co-administration of PEGylated uricase and MTX as part of its proposed treatment approaches.
Conclusion
Swarnendra K. Verma’s patent work centers on infusion protocols and combination treatment strategies for gout, reflecting an innovation focus on PEGylated uricase therapy.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile